US

Torque collects $25 mln Series A

Cambridge, Massachusetts-based Torque, an immuno-oncology company, has raised $25 million in Series A funding. The investor was Flagship Pioneering.

Syapse nabs $30 mln Series D

San Francisco-based Syapse, a provider of precision medicine solutions, has raised $30 million in Series D financing. The backers included Ascension Ventures, GE Ventures, Intermountain Healthcare Innovation Fund, Safeguard Scientifics, Social Capital, Amgen Ventures, Medidata Solutions, Merck Global Health Innovation Fund and Roche Venture Fund.

Quantum Circuits hauls in $18 mln Series A

Quantum Circuits Inc, a quantum computing startup, has raised $18 million in Series A funding. Canaan and Sequoia led the round with participation from Tribeca Venture Partners, Osage University Partners and Fitz Gate Ventures. In addition to the funding, Brendan Dickinson of Canaan and Bill Coughran of Sequoia are joining QCI's board.

Genialis rakes in $2.3 mln seed

Genialis, a builder of genomics software for biologists, has secured $2.3 million in seed funding. Redalpine Venture Capital and First Star Venture Capital led the round with participation from Pikas d.o.o.

Collective Medical rakes in $47.5 mln Series A

Salt Lake City-based Collective Medical, a provider of care collaboration solutions, has secured $47.5 million in Series A funding. Kleiner Perkins Caufield & Byers led the round with participation from Bessemer Venture Partners, Maverick Ventures, Kaiser Permanente Ventures, Providence Ventures, Peterson Ventures and Epic Ventures.

Debt collection platform provider TrueAccord attracts $22 mln

San Francisco-based TrueAccord, a provider of a debt collection platform, has secured $22 million in funding. Arbor Ventures led the round with participation other investors that included Nyca Investment Partnership, Assurant Growth Investing, Caffeinated Capital Fund, Felicis Venture, TenOneTen and Crystal Towers.

French biotech company Scipio Bioscience picks up seed funding

Paris-based Scipio Bioscience, a biotechnology company, has raised 1.2 million euros in seed funding. The investors were Seventure Partners and High-Tech Gründerfonds.

ImmusanT lands $40 mln Series C

Cambridge, Massachusetts-based ImmusanT, a developer of treatments for celiac disease, has closed $40 million in Series C financing. The investors were ARCH Venture Partners and Vatera Healthcare Partners. In conjunction with the funding, Dr. Steven Gillis and Dr. Thomas Daniel have joined ImmusanT's board of directors. MTS Health Partners LP served as the adviser on the transaction.

Choozle nets $6 mln Series B

Denver-based Choozle, a programmatic advertising platform, has raised $6 million in Series B funding. Choozle’s investors include Great Oaks Venture Capital.

LeanTaaS scores $26 mln Series B

Silicon Valley-based LeanTaaS, Inc., a provider of software for healthcare providers, has raised $26 million in Series B funding. The investor was Insight Venture Partners.